Thursday, November 10, 2011

Adulteration in herbal drugs

Delhi Institute of Pharmaceutical Sciences & Research (DIPSAR) have confirmed that many ayurvedic and Unani formulations currently marketed in the country by various manufacturing companies are adulterated and mixed with Sildenafil or Tadalfil VIAGRA type drugs in ayurvedic aphrodisiac formulation including Titanic K2. These formulations, now available in the market, are combinations of allopathic and ayurvedic contents.
   According to Prof. S. S. Aggarwal, Principal DIPSAR, last year the institute had collected samples from NCR of Delhi, out of 16 samples-4 were found to contain Sildenafil and one found to contain Tadalafil. In 2011 team have collected 34 samples of aphrodisiac sold in NCR of Delhi out of which 28 were oral preparation and 6 were oils, and out of which 5 were found to contain Sildenafil and one contain Tadalafil. It was surprising that the quantity was as much high as 72 mg where as the normal therapeutic dose is 25-50 mg for Sildenafil and 10-20 mg for Tadalafil.
Last year all the reports were published in news paper, journal etc. as a consequences of this two brands i.e "Musli Power Xtra" and "2 Much gold" stopped adulteration the drug while thee previous Brands still doing adulteration and three more brands i.e.X-Power, Goli Wajid Ali shah and Mughl-E-Azam contain sildenafil the Titanic K2 has started adulteration with Tadalafil instead of Sildenafil.

The products are ‘Supersonic’, manufactured by Renovison Exports Pvt. Ltd., S.P.Verma Road, Patna, Bihar , ‘Titanic K2’, manufactured by Sun Laboratories,ORAI, UP, ‘Mughal-E-Azam’, a product of Hashmi Unani Pharmacy, Amroha, UP,  Goli wajid Ali shah’, manufactured by New Sharma Laboratiries, Patpar Ganj, Delhi, X-power’,manufactured by Guru Pharmaceuticals, Faridabad, Haryana and 'Sikander-E-Azam' of Hashmi Unani Pharmacy, Amroha, UP.
Institute have collected the samples of the drugs from the local chemists in Delhi NCR and they have the bills for the same for records. Their tests lasted for six months to find out the real contents.They said the method used for conducting the analysis test of the formulations are various types including the latest one by using HPTLC, HPLC and LC-MS instruments.
In the quantitative test using the above instruments it was found that products were contained the ingredients of phosphodiesterase (sildenafil or tadlafil) with different quantities in mg per tablet or capsule.
In the drug ‘Supersonic’ (batch NO- 14) the sildenafil presence per tablet/capsule was ‘119.00 mg. In ‘Titanic K2’, (Batch No—27), it was 71.00 mg per tablet/capsule. Where as, in ‘Sikander e Azam’, (Batch No—2), the presence of sildenafil per tablet/capsule was 76.00 mg.
The same content was also found in the drug, ‘2 Much Gold’,( Batch No—152), and the quantity was 2.01 mg per tablet/capsule.
Consequences of such adulteration may be fatal and in past deaths have been reported in western countries. When such drugs are taken with nitrates to cardiac patients who are suffering from Angina Pectoris immense vasodilatation may accur which may lead to serious fatal conditions.
The officials said herbal medicines rarely have a quick onset of action and it is often seen that they produce mild to moderate action. Furthermore they elicit their response on prolonged dosing. The manufacturers of these companies were claiming to cure the problem of erectile dysfunction with single dose.
According to DIPSAR report some of the manufacturers are not even mentioning the date of expiry on their label which is a violation of Drugs and Cosmetics rule 1945 and some of these manufacturers are promoting their products for erectile disfunction by giving obscene pictures in their packets which is a violation of drugs and magic remedies act 1954.
DIPSAR has sent the reports to the DCGI and copies were sent to the CDSCO offices and also to the health ministries of central government and Delhi government. It has advised the concerned authorities to conduct strict pharmacovigilance of these herbal products and they should be prohibited from marketing openly to public.

No comments:

Post a Comment